BE878084R - Procede d'encapsulation d'une matiere biologique labile. - Google Patents
Procede d'encapsulation d'une matiere biologique labile.Info
- Publication number
- BE878084R BE878084R BE0/196609A BE196609A BE878084R BE 878084 R BE878084 R BE 878084R BE 0/196609 A BE0/196609 A BE 0/196609A BE 196609 A BE196609 A BE 196609A BE 878084 R BE878084 R BE 878084R
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- encapsulation
- biological material
- phase
- labile biological
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
- B01J13/16—Interfacial polymerisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/5375—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by changing the physical or chemical properties of the medium or immunochemicals, e.g. temperature, density, pH, partitioning
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Description
<EMI ID=1.1> <EMI ID=2.1> <EMI ID=3.1> <EMI ID=4.1> <EMI ID=5.1> relativement épais est produit autour des gouttelettes lors <EMI ID=6.1> <EMI ID=7.1> <EMI ID=8.1> <EMI ID=9.1> <EMI ID=10.1> <EMI ID=11.1> <EMI ID=12.1> 'phases et remises en Suspension dans une nouvelle phase: <EMI ID=13.1> la polarité diffère de celle de la phase continue utilisée à l'origine. Selon, la présente invention, un solvant miscible <EMI ID=14.1> <EMI ID=15.1> <EMI ID=16.1> <EMI ID=17.1> <EMI ID=18.1> polymères précités, les Solvants préférés pour la phase <EMI ID=19.1> forme pour le diluer selon ce qui est, approprié . L'affinité <EMI ID=20.1> <EMI ID=21.1> de monomères., très divers. qui. forment des. chaînes polymères.. <EMI ID=22.1> <EMI ID=23.1> <EMI ID=24.1> former une phase aqueuse discontinue ou phase- de gouttelettes" La dimension des. gouttelettes, détermine la .dimension des- <EMI ID=25.1> spécifique', on peut utiliser un où plusieurs filtres pour <EMI ID=26.1> capsules.: Pour. un exposé détaillé sur le procédé permettant de faire varier la dimension 'des. capsules, on' peut se référer ; <EMI ID=27.1> <EMI ID=28.1> été. produites, un second. monomère hydrophobe, soluble dans la -phase continue et capable de former un polymère par <EMI ID=29.1> est introduit dans la suspension. Une polymérisation ne se.' <EMI ID=30.1> <EMI ID=31.1> être choisis panai ceux présentant des propriétés convenables <EMI ID=32.1> <EMI ID=33.1> on ne peut exercer qu'un, contrôle de réglage grossier sur la <EMI ID=34.1> <EMI ID=35.1> <EMI ID=36.1> dans la "phase discontinue. Ainsi, on peut; -régler l'épaisseur <EMI ID=37.1> <EMI ID=38.1> <EMI ID=39.1> Dans une forme préférée de. réalisation, la phase continue pour la première étape de polymérisation est-choisie <EMI ID=40.1> <EMI ID=41.1> l'affinité de la phase continue pour le prêter monomère; .est. <EMI ID=42.1> <EMI ID=43.1> <EMI ID=44.1> différente. La poursuite de la polymérisation, est ensuite <EMI ID=45.1> <EMI ID=46.1> <EMI ID=47.1> -Dans l'autre procédé de la présente invention, l'affinité de la phase continue pour le premier monomère est . augmentée ou diminuée"; selon les désirs, par la dilution de la phase conti- <EMI ID=48.1> <EMI ID=49.1> <EMI ID=50.1> <EMI ID=51.1> <EMI ID=52.1> <EMI ID=53.1> dont la limite de perméabilité; est inférieure 5 environ <EMI ID=54.1> <EMI ID=55.1> miscibles entre eux;. 2) les solvants respectifs doivent, être du type <EMI ID=56.1> <EMI ID=57.1> <EMI ID=58.1> <EMI ID=59.1> <EMI ID=60.1> <EMI ID=61.1> <EMI ID=62.1> <EMI ID=63.1> <EMI ID=64.1> <EMI ID=65.1> <EMI ID=66.1> <EMI ID=67.1> <EMI ID=68.1> l'aide d'une tige d'agitation.... <EMI ID=69.1> <EMI ID=70.1> <EMI ID=71.1> <EMI ID=72.1> <EMI ID=73.1> <EMI ID=74.1> <EMI ID=75.1> <EMI ID=76.1> pendant 20 minutés supplémentaires. Deux minutes avant ' , - <EMI ID=77.1> <EMI ID=78.1> <EMI ID=79.1> <EMI ID=80.1> <EMI ID=81.1> <EMI ID=82.1> <EMI ID=83.1> <EMI ID=84.1> <EMI ID=85.1> <EMI ID=86.1> <EMI ID=87.1> <EMI ID=88.1> albumine de bovin comme -matières . de charge. Les substances - <EMI ID=89.1> plupart des anticorps) ne peuvent pénétrer ou traverser les membranes. Des substances dont le'poids moléculaire est <EMI ID=90.1> <EMI ID=91.1>
Claims (1)
- <EMI ID=92.1><EMI ID=93.1><EMI ID=94.1><EMI ID=95.1><EMI ID=96.1>obtient une couché supplémentaire de polymère autour des.gouttelettes de la phase, discontinue.<EMI ID=97.1><EMI ID=98.1><EMI ID=99.1><EMI ID=100.1><EMI ID=101.1> <EMI ID=102.1><EMI ID=103.1><EMI ID=104.1><EMI ID=105.1><EMI ID=106.1><EMI ID=107.1><EMI ID=108.1>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93117778A | 1978-08-04 | 1978-08-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE878084R true BE878084R (fr) | 1979-12-03 |
Family
ID=25460332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/196609A BE878084R (fr) | 1978-08-04 | 1979-08-03 | Procede d'encapsulation d'une matiere biologique labile. |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS5544387A (fr) |
BE (1) | BE878084R (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6132492A (en) * | 1994-10-13 | 2000-10-17 | Advanced Technology Materials, Inc. | Sorbent-based gas storage and delivery system for dispensing of high-purity gas, and apparatus and process for manufacturing semiconductor devices, products and precursor structures utilizing same |
-
1979
- 1979-08-03 BE BE0/196609A patent/BE878084R/fr not_active IP Right Cessation
- 1979-08-03 JP JP9874379A patent/JPS5544387A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6152735B2 (fr) | 1986-11-14 |
JPS5544387A (en) | 1980-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ren et al. | Rapid Room‐Temperature Gelation of Crude Oils by a Wetted Powder Gelator | |
Loxley et al. | Preparation of poly (methylmethacrylate) microcapsules with liquid cores | |
US3959457A (en) | Microparticulate material and method of making such material | |
US4459378A (en) | Monodisperse polymer particles and dispersions thereof | |
Xia et al. | Protein-polyelectrolyte complexes | |
Najib et al. | Characteristics of the in vitro release of ibuprofen from polyvinylpyrrolidone solid dispersions | |
EP0154620B1 (fr) | Structure à membranes poreuses, procédé de fabrication de cette structure ainsi que ses applications | |
DE2303866A1 (de) | Verfahren zur herstellung von mikrokapseln | |
Burgess | Complex coacervation: microcapsule formation | |
Silvestri et al. | Polymeric devices containing imprinted nanospheres: a novel approach to improve recognition in water for clinical uses | |
Kallakunta et al. | A Gelucire 44/14 and labrasol based solid self emulsifying drug delivery system: formulation and evaluation | |
Shukla et al. | Preparation and characterization of microcapsules of water-soluble pesticide monocrotophos using polyurethane as carrier material | |
BE878084R (fr) | Procede d'encapsulation d'une matiere biologique labile. | |
Chen et al. | Surface shear viscosity and protein-surfactant interactions in mixed protein films adsorbed at the oil-water interface | |
US6228291B1 (en) | Process for preparing controlled-released chitosan microcapsule | |
Medina et al. | Chiral polymers and polymeric particles for enantioselective crystallization | |
Rizzelli et al. | Preparation of non-aqueous Pickering emulsions using anisotropic block copolymer nanoparticles | |
Chan et al. | Block copolymer nanoparticles are effective dispersants for micrometer-sized organic crystalline particles | |
Cui et al. | Tuning the morphology, network structure, and degradation of thermo-sensitive microgels by controlled addition of degradable cross-linker | |
DE3149517A1 (de) | Verfahren und vorrichtung zum granulieren eines pulvergemisches | |
US3494872A (en) | Manufacture of minute capsules,en masse,and dewatering their walls | |
Yun et al. | Preparation and characterization of molecularly imprinted polymers for the selective separation of 2, 4-dichlorophenoxyacetic acid | |
CA2243437C (fr) | Procede pour la preparation d'enrobes denses a l'emulsion, et emulsion pour y parvenir | |
US3970577A (en) | Water-dispersible aluminium pastes | |
Esumi et al. | Interaction between aerosol OT and poly (vinylpyrrolidone) on alumina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: DAMON BIOTECH INC. Effective date: 19871130 |